Cabot (CBT) to Release Quarterly Earnings on Monday

Key Points

• Cabot is expected to report Q3 fiscal 2026 results after the market closes on August 3, with analysts forecasting $1.66 in earnings per share and $943.2 million in revenue. The earnings call is scheduled for August 4 at 8:00 a.m. ET.
• In its previous quarter, Cabot earned $1.61 per share, exceeding estimates of $1.47, while revenue rose above expectations but declined 3.4% year over year. Analysts expect approximately $6 in EPS for fiscal 2026 and $7 for fiscal 2027.
• Cabot recently declared a quarterly dividend of $0.4725 per share, equivalent to a 2.1% yield, while Wall Street maintains a consensus “Hold” rating and an average price target of $85.80.

Cabot (NYSE:CBT - Get Free Report) is anticipated to announce its Q3 2026 results after the market closes on Monday, August 3rd. Analysts expect the company to post earnings of $1.66 per share and revenue of $943.1640 million for the quarter. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Parties are encouraged to explore the company's upcoming Q3 2026 earning report page for the latest details on the call scheduled for Tuesday, August 4, 2026 at 8:00 AM ET.

Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, topping the consensus estimate of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.30 million. During the same quarter in the previous year, the firm posted $1.90 earnings per share. The company's revenue for the quarter was down 3.4% on a year-over-year basis. On average, analysts expect Cabot to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Cabot Stock Up 0.0%

Cabot stock opened at $90.15 on Monday. The firm has a 50 day moving average price of $86.94 and a 200-day moving average price of $78.79. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51. Cabot has a twelve month low of $58.33 and a twelve month high of $94.53. The company has a market capitalization of $4.65 billion, a P/E ratio of 17.04, a P/E/G ratio of 11.73 and a beta of 0.83.

Cabot Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be paid a $0.4725 dividend. The ex-dividend date is Friday, August 28th. This represents a $1.89 annualized dividend and a yield of 2.1%. Cabot's dividend payout ratio is presently 35.73%.

Hedge Funds Weigh In On Cabot

A number of large investors have recently made changes to their positions in the stock. Public Employees Retirement System of Ohio grew its position in shares of Cabot by 15.4% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,202 shares of the specialty chemicals company's stock valued at $80,000 after purchasing an additional 160 shares in the last quarter. Janney Montgomery Scott LLC lifted its holdings in Cabot by 2.6% during the 4th quarter. Janney Montgomery Scott LLC now owns 6,298 shares of the specialty chemicals company's stock worth $417,000 after purchasing an additional 161 shares in the last quarter. Geneos Wealth Management Inc. lifted its holdings in Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company's stock worth $38,000 after purchasing an additional 364 shares in the last quarter. Global Retirement Partners LLC boosted its stake in Cabot by 1,606.9% in the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company's stock worth $33,000 after purchasing an additional 466 shares during the period. Finally, Caitong International Asset Management Co. Ltd boosted its stake in Cabot by 709.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 534 shares of the specialty chemicals company's stock worth $41,000 after purchasing an additional 468 shares during the period. 93.18% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. UBS Group increased their price objective on Cabot from $81.00 to $86.00 and gave the company a "neutral" rating in a report on Friday, May 8th. Mizuho upped their price target on Cabot from $80.00 to $90.00 and gave the company a "neutral" rating in a research report on Thursday, June 25th. Wall Street Zen upgraded Cabot from a "hold" rating to a "buy" rating in a research note on Sunday, June 14th. Weiss Ratings reissued a "hold (c)" rating on shares of Cabot in a report on Tuesday, May 26th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Cabot from $68.00 to $70.00 and gave the company an "underweight" rating in a report on Wednesday, May 13th. Two equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $85.80.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.